News

3 Major Issues Wall Street Should Be Aware Of

1 Mins read

This article was written by

Leo Nelissen is a long-term investor and macro-focused strategist with a passion for dividend growth, high-quality compounders, and structural investment themes. He combines big-picture macro analysis with bottom-up stock research to identify durable businesses with strong cash-flow potential. Leo also writes for Main Street Alpha, where he publishes deeper-dive research and actionable investment ideas for long-term investors.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of AM either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read the full article here

Related posts
News

Viper Energy: A High-Margin Royalty Machine With 10% Yield Potential (NASDAQ:VNOM)

1 Mins read
This article was written by Follow English and Brazilian Portuguese translator, proofreader, editor, and content writer specializing in Finance, Economics, and Investments….
News

Capital Markets Remain Unsettled With Oil Above $100

1 Mins read
Marc Chandler has been covering the global capital markets in one fashion or another for 25 years, working at economic consulting firms…
News

Camp4 Therapeutics: Strong Cash Runway As CMP-002 Moves Toward Human Trials (NASDAQ:CAMP)

2 Mins read
This article was written by Follow I hold a Master’s degree in Cell Biology and began my career working for several years…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *